Functions of the CSB Protein at Topoisomerase 2 Inhibitors-Induced DNA Lesions
Open Access
- 22 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Topoisomerase 2 (TOP2) inhibitors are drugs widely used in the treatment of different types of cancer. Processing of their induced-lesions create double-strand breaks (DSBs) in the DNA, which is the main toxic mechanism of topoisomerase inhibitors to kill cancer cells. It was established that the Nucleotide Excision Repair pathway respond to TOP2-induced lesions, mainly through the Cockayne Syndrome B (CSB) protein. In this paper, we further define the mechanism and type of lesions induced by TOP2 inhibitors when CSB is abrogated. In the absence of TOP2, but not during pharmacological inhibition, an increase in R-Loops was detected. We also observed that CSB knockdown provokes the accumulation of DSBs induced by TOP2 inhibitors. Consistent with a functional interplay, interaction between CSB and TOP2 occurred after TOP2 inhibition. This was corroborated with in vitro DNA cleavage assays where CSB stimulated the activity of TOP2. Altogether, our results show that TOP2 is stimulated by the CSB protein and prevents the accumulation of R-loops/DSBs linked to genomic instability.Funding Information
- Canadian Institutes of Health Research
- Fundação de Amparoà Pesquisa do Estado do Rio Grande do Sul
- National Cancer Institute
This publication has 35 references indexed in Scilit:
- GST-His purification: A Two-step Affinity Purification Protocol Yielding Full-length Purified ProteinsJournal of Visualized Experiments, 2013
- Tdp2: A Means to Fixing the EndsPLoS Genetics, 2013
- Topoisomerase AssaysCurrent Protocols in Pharmacology, 2012
- Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cellsDNA Repair, 2010
- Top1- and Top2-mediated topological transitions at replication forks ensure fork progression and stability and prevent DNA damage checkpoint activationGenes & Development, 2007
- Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II–Mediated Form of Cell DeathCancer Research, 2006
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- A Two-drug Model for Etoposide Action against Human Topoisomerase IIαOnline Journal of Public Health Informatics, 2003
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976